Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Passage Bio, Inc. (PASG) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Passage Bio, Inc. (PASG) on November 12, 2026 is 4.09 $, +2.25 % on the day. Over 52 weeks the stock traded between 3.29 $ and 20.00 $; the price now sits 5 % of the way up that range. Over the past year the price changed by −48.05 %. Market capitalization is 12.52 million $, rank 121 among 134 stocks of the same industry with a known capitalization.
Passage Bio, Inc. trades on Nasdaq under the ticker PASG. The company belongs to the Health care sector. The trading history on this page starts on 28 February 2020.
Over the past 52 weeks PASG has traded between 3.29 $ and 20.00 $. As of 12 November 2026 the price stood 4.25% of the way from the 52-week low to the high.
Over one year PASG shares fell 48.05%; over six months they fell 27.54%. Volatility over 90 days is 79.09%. Dividends are not included: this is price change only, as of 12 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 2.8, above the sector median of 2.4. Calculated from reports for the period ending 30 June 2026.
PASG has a return on equity of −810.41%, below the sector median of −40.58%. Return on assets is −143.44%, below the sector median of −30.08%.